Here Come the Little Electric Pickup Trucks

(Bloomberg) —Having zipped from six-figure sedans to Costco-crushing SUVs, electrification is finally zeroing in on the auto industry’s most esoteric form: the tiny pickup truck. At least two major carmakers are considering adding small, battery-powered pickups to their growing parade of EVs.At General Motors Co., spokesman Stuart Fowle says a pint-sized pickup is one of several electric options mocked up by a team of engineers and designers focused on developing affordable models, though “at this point it’s simply a design proposal.” “There are still some steps before anything moves to production consideration,” he says.Nissan Motor Co., meanwhile, is eyeing its next wave of EVs and has promised to make two battery-powered models at its Mississippi plant. The first is the Ariya EV, which just hit the market. As for the second, advisory board member Tyler Slade reportedly said an electric version of the brand’s Frontier pickup would be logical. A Nissan spokesman called the report speculation and said the company does not comment on future product plans.

Tiny trucks are a natural target for electrification. They’re already lighter and more aerodynamic than their sturdier pickup siblings, which makes it easier for engineers to outfit them with smaller batteries. The smaller batteries will make these trucks lighter still — a flywheel-type equation that works against the auto industry when it’s churning out massive electric SUVs. Small electric trucks are also relatively cheap to manufacture, which helps offset battery costs.

And while few drivers need a small pickup — they offer not much more utility than a similar-sized sedan, don’t handle as well and often have half as many doors — people seem to love them, especially Americans. How they look. How they feel to sit in. What they can do, even if they seldom actually do it.

“There are an awful lot of people who are like ‘I want a truck, but I don’t really need a truck, so this little run-around pickup is fine,’” says Bloomberg Intelligence analyst Kevin Tynan. “For a car company, it’s a great little strategy that nobody is really talking about.”

Auto executives tend to green-light a wave of tiny trucks every 20-30 years, typically when gasoline prices spike. In the 1970s, they gave us the Chevrolet LUV, Ford Courier and Subaru BRAT. In the ‘90s, it was the Chevrolet S-10 and Dodge Dakota. Today, we have the Ford Maverick and Hyundai Santa Cruz. Both hit the market in late 2021; their swift popularity is no doubt a factor in carmakers considering similar electric alternatives.

Although it starts at just $22,195, the Maverick generated some $2.1 billion in revenue for Ford last year, according to Bloomberg estimates, nearly as much as its larger sibling, the Ford Ranger. Critically, it didn’t seem to pull buyers away from Ford’s other trucks; the Maverick instead attracted drivers who typically go for car-shaped cars.

The truck has proved so popular, Ford intermittently stopped taking orders to allow its factory to catch up.

The Santa Cruz, meanwhile, let Hyundai tap into America’s lucrative truck market for the first time. In developing the vehicle, the company said it found a lot of people in focus groups who drive small SUVs but yearn for more cargo capability. The Santa Cruz has resonated with that crowd, helping the brand post a 17% increase in vehicles sold in the second half of 2022.

Americans’ menu of tiny trucks will almost definitely keep growing. Thanks to the combination of consumer interest and the strong economics for carmakers, forecaster LMC Automotive sees the compact-pickup market in the US — gas-guzzling, hybrid and electric — swelling to as many as 200,000 vehicles a year by mid-decade, which would be nearly double its current size.

At GM, Fowle says the company’s engineering-and-design working group is dreaming up EVs that can “be affordable from the start versus a decontenting exercise.” In other words, the company is looking to design electric models with a focus on affordable parts, materials and solutions, rather than stripping frills away from a more opulent model.

Conveniently, GM doesn’t currently make any truck the same relative size and price as the Maverick or Santa Cruz. Its closest product is the mid-sized Chevrolet Colorado, which starts around $31,000 and burns a gallon of gas at least every 24 miles.

More stories like this are available on

bloomberg.com

 

©2023 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More